IMPORTANCE Adults late after total correction of tetralogy of Fallot (TOF) are at risk for major complications. Cardiovascular magnetic resonance (CMR) imaging is recommended to quantify right ventricular (RV) and left ventricular (LV) function. However, a commonly used risk model by Khairy et al requires invasive investigations and lacks CMR imaging to identify high-risk patients.
C urrently, survival into the fourth or fifth decade after repair of tetralogy of Fallot (TOF) is common owing to advancements in the surgical and medical management. 1 Nonetheless, cardiovascular morbidity remains substantial and includes an increased risk for life-threatening ventricular tachyarrhythmias and sudden death.
2-4 Cardiovascular magnetic resonance (CMR) imaging is considered the golden standard in quantifying right ventricular (RV) and left ventricular (LV) volume and function. 5 Although RV and/or LV dysfunction have been linked to adverse events, it remains unclear which thresholds can be used in risk stratification. 3, 6, 7 In addition, the commonly used risk model by Khairy et al 8, 9 includes 2 invasive risk factors (inducible sustained ventricular tachycardia [VT] and LV end-diastolic pressure ≥12 mm Hg) but no CMR parameters. Therefore, we sought to identify valid thresholds for RV and LV function to predict major adverse events and to implement these in a noninvasive risk model, combined with the noninvasive risk factors proposed by Khairy et al.
8,9
Methods
Cohort and Methods
For this retrospective, multicenter cohort study, we identified all adult patients with surgically repaired TOF enrolled in the nationwide Congenital Corvitia (CONCOR) registry, 10 within 1 of 5 participating centers. The data analysis was conducted from January to December 2016. Inclusion criteria consisted of (1) repaired TOF with pulmonary stenosis or atresia and (2) completed CMR examination more than 6 months before last follow-up. Medical records were reviewed to obtain patient, clinical, and surgical data. The CONCOR registry was approved by the ethics board of all participating centers and all patients provided informed consent. The need to obtain institutional review board approval for this current analysis was waived as patients were not subject to procedures or required to follow rules of behavior. Locally performed CMR imaging data, closest to CONCOR inclusion, were obtained. Patients in whom quantitative assessment could not be performed reliably in at least 1 ventricle were excluded from this study. Trabeculations were included in the blood pool and the RV outflow tract was included as part of the RV volumes.
6,11
Follow-up time started at the date of baseline CMR or at the CONCOR registry inclusion date when CMR was performed prior to inclusion. The composite primary outcome was defined as all-cause mortality or ventricular arrhythmia, defined as aborted cardiac arrest or documented ventricular fibrillation, sustained VT lasting 30 seconds or longer, or recurrent documented symptomatic nonsustained VT requiring intervention such as cardioversion or ablation therapy.
Statistical Analysis
Data were presented using frequencies and percentages when categorical, and mean and SD or median and interquartile range when continuous. Multivariable Cox hazards regression models were used to test the change in C statistic and the 2-category net reclassification improvement (NRI) (at cutoff on 5-year event rate) of different models. The NRI was calculated after estimating 5-year survival probability (according to different models) for all patients, and dichotomizing at event rate. This method assesses the ability of the extended model to appropriately reclassify patients with and without the primary end point to high/low risk. 8, 12 In addition, the 2-category NRI was used similarly to select optimal thresholds for RV and LV dysfunction in multivariable models correcting for noninvasive components of the Khairy et al 8,9 risk score. Finally, points were attributed to the components of the final noninvasive model, as previously proposed by Khairy et al. 8, 9 The C statistic of the final point-based noninvasive model was determined in 1000 bootstrap samples with replacement of cases.
P < .05 was considered statistically significant. Statistical analyses were performed using SPSS version 22.0 (IBM) and R version 3.3.1 (R core team).
Results
Of 755 patients with repaired TOF enrolled in the CONCOR registry within the participating centers, 575 patients (57% male; mean [SD] age, 31 [11] years; 7% pulmonary atresia) fulfilled the inclusion criteria and comprised the study population ( Table 1) . Of 180 excluded patients, 41 (23%) had a pacemaker or an implantable cardioverter defibrillator (ICD) implanted before inclusion in the registry. The other excluded patients did not undergo CMR examination for various other reasons such as claustrophobia or inability to comply with instructions.
Occurrence of Primary End Point
During a mean (SD) follow-up of 7.1 (3.5) years (median, 7.1 years; interquartile range, 4.7-9.8), 35 of 575 patients (6.1%) experienced the composite primary outcome of all-cause death (n = 13, 1 after ventricular arrhythmia), cardiac arrest/ ventricular fibrillation (n = 8), sustained VT (n = 4), or recurrent symptomatic nonsustained VT (n = 11). One death (8%) was classified as sudden cardiac, 5 (38%) as heart failure, 1 (8%) as
Key Points
Question What is the value of cardiovascular magnetic resonance imaging in noninvasive risk stratification of adults with tetralogy of Fallot?
Findings In this study, the optimal cardiovascular magnetic resonance thresholds for ventricular function were right ventricular ejection fraction less than 30% and left ventricular ejection fraction less than 45%, and they were independently predictive of death and ventricular arrhythmias. These independently predictive thresholds may be implemented in noninvasive risk stratification combined with the noninvasive components of the Khairy et al risk model.
Meaning
In patients with repaired tetralogy of Fallot, right ventricular ejection fraction less than 30% and left ventricular ejection fraction less than 45% may be implemented in noninvasive risk stratification. renal/cardiac failure, 1 (8%) as perioperative bleeding, and 5 (38%) as noncardiac or unknown. Baseline variables associated with the primary outcome are listed in Table 1 .
Noninvasive Risk Stratification
The mean (SD) RV EF was 44% (10%) and mean (SD) LV EF was 53% (8%). There was a modest correlation between RV EF and LV EF (R, 0.36; 95% CI, 0.29-0.44; P < .001) (eFigure in the Supplement). Both variables were associated with the primary outcome in multivariable analysis ( Table 2 ). The C statistic of the noninvasive components of the Khairy et al 8,9 score was 0.64 (95% CI, 0.54-0.73) ( Table 3) . Right ventricular EF and LV EF had additional value when added as continuous variables to the model (2-category NRI, 0.15 and change C statistic, 0.09).
The primary outcome occurred in 12 of 54 patients (22%) with severe RV dysfunction (RV EF <30%) compared with only Table 3 ). There was no interaction between previous pulmonary valve replacement and RV EF less than 30% or LV EF less than 45%, indicating thresholds are applicable in patients with and without pulmonary valve replacement.
When compared with the model with RV EF and LV EF as continuous predictors, a model including RV EF less than 30% and LV EF less than 45% as dichotomized predictors only was noninferior (2-category NRI, 0.07; change C statistic, 0.03). The C statistic of the final noninvasive point-based risk model, 
Discussion
To our knowledge, this study is among the largest to investigate CMR parameters as predictors of major outcomes in TOF and will further define its role in clinical decision-making.
3,4
The newly quantified thresholds (RV EF <30% and LV EF <45%) for biventricular dysfunction were independently predictive and had additional value in risk stratification compared with the noninvasive components of the Khairy et al 8 risk model.
Risk stratification may identify patients with increased risk for life-threatening ventricular arrhythmias and sudden cardiac death who could benefit from ICD implantation.
9 Our reported biventricular thresholds (RV EF <30% and LV EF <45%) were different compared with those reported in the study by Valente et al (RV EF <48% and LV EF <55%).
3 These differences may be related to the specific analysis performed to determine optimal thresholds in our study and small differences in study design and CMR techniques. Furthermore, we found that combined biventricular dysfunction was clinically highly important, suggesting adverse effects of RV and LV dysfunction are cumulative. A risk model proposed by Khairy et al 8 is commonly used in patients with TOF, although 2 variables (inducible sustained VT and LV end-diastolic pressure ≥12 mm Hg) require invasive investigations, and no CMR variables were included in the original model. This risk model was constructed in a selected group of TOF ICD recipients, which may limit its use to identify patients for ICD implantation. 8, 9 In the present study, CMR imaging had additional value in noninvasive risk stratification, combined with noninvasive components proposed by 
Study Limitations
Although only patients from university centers were included in this study, almost all patients with TOF receive medical care in university centers in the Netherlands. Patients in the CONCOR registry without CMR imaging for various reasons were excluded. Furthermore, there was no central core laboratory and CMR was performed according to local protocols with variation in timing. This study lacked data on biventricular mass, exercise capacity, invasive risk factors (inducible sustained VT and LV end-diastolic pressure), and other hemodynamic anomalies (eg, tricuspid regurgitation). Last, future studies are needed to validate the thresholds and the adapted noninvasive risk model.
Conclusions
This large multicenter, prospective registry of patients with repaired TOF identified thresholds for ventricular dysfunction (RV EF <30% and LV EF <45%) to predict major adverse clinical outcomes. A combination of both thresholds with the noninvasive components proposed by Khairy et al 8,9 may be used for noninvasive risk stratification. With each passing decade of experience since the first successful surgical procedures, we have learned more and more about how the myocardium behaves in response to pressure and volume loading, and we have seen more heart failurerelated complications as a result. Even when the septal defect is closed and the pulmonary valve replaced and competent, residual biventricular dysfunction (right and/or left, systolic and/or diastolic) may become more pronounced over time and affect long-term outcome. Cumulative studies now paint a convincing picture of a cause-effect relationship between myocardial dysfunction and death or ventricular arrhythmia.
Such a relationship is not surprising based on what is known about myocardial behavior in other cardiac conditions. We know that myocardial dysfunction is a result of many different insults, and that it is a direct cause of arrhythmia, heart failure, and death. For example, in TOF specifically, there is ample evidence that fibrosis, one measurable indicator of myocardial change, begins early in life, perhaps during cardiac surgery, 2, 3 and that the presence of fibrosis is correlated with the risk for arrhythmia and adverse outcome.
The newest study, and one of the largest, in this growing chain of evidence is by Bokma et al. 4 The authors tapped into the Concor registry in the Netherlands to identify 575 patients with TOF, each with prior cardiac magnetic resonance (CMR) imaging. The patients were followed up for a mean of more than 7 years. Their study confirms and reiterates this relationship between myocardial dysfunction and clinical events. A few specific findings from their retrospective study are worth noting. First, the number of patients experiencing death (n = 13) or ventricular arrhythmia (n = 23) translates into an annual incidence of these events of a bit less than 1% per year. This is congruous with other studies using similar end points, 5,6 suggesting that the included population is a representative one.
It is important to note that although this rate seems low, the mean (SD) age of this population is 31 (11) years, meaning the incidence of death is several-fold greater than the population risk for a 31-year-old individual (according to the US Social Security actuarial life table for 2013, the probability of death at age 31 years was at 0.15% for men and 0.07% for women). 7 This is by no means trivial. Second, the authors sought to develop a more clinicianfriendly prediction model than previous studies. It is based solely on noninvasive metrics that are thus more easily obtained. This model was compared with a 2008 study of patients with TOF with implantable cardioverter defibrillators 
